Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Accenture
Fuji
QuintilesIMS
Moodys
Johnson and Johnson
Federal Trade Commission
Cipla
Teva
UBS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,894,988

« Back to Dashboard

Which drugs does patent 8,894,988 protect, and when does it expire?


Patent 8,894,988 protects OXYCONTIN and is included in one NDA. There have been two Paragraph IV challenges on Oxycontin.

This patent has one hundred and seventy-one patent family members in thirty-nine countries.

Summary for Patent: 8,894,988

Title:Tamper resistant dosage forms
Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
Inventor(s): McKenna; William H. (Yonkers, NY), Mannion; Richard O. (Furlong, PA), O'Donnell; Edward P. (Basking Ridge, NJ), Huang; Haiyong H. (Princeton, NJ)
Assignee: Purdue Pharma L.P. (Stamford, CT) Purdue Pharmaceuticals L.P. (Wilson, NC)
Application Number:13/900,963
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Process; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-001Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-002Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-003Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-005Apr 5, 2010RXYesYes► Subscribe► Subscribe► SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-006Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-007Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,894,988

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,545,380Tamper resistant dosage forms► Subscribe
9,492,392Tamper resistant dosage forms► Subscribe
8,911,719Tamper resistant dosage forms► Subscribe
9,492,390Tamper resistant dosage forms► Subscribe
9,486,412Tamper resistant dosage forms► Subscribe
8,808,741Tamper resistant dosage forms► Subscribe
9,084,816Tamper resistant dosage forms► Subscribe
9,492,393Tamper resistant dosage forms► Subscribe
9,486,413Tamper resistant dosage forms► Subscribe
9,095,614Tamper resistant dosage forms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,894,988

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
CroatiaP20130434► Subscribe
CroatiaP20130433► Subscribe
CroatiaP20120670► Subscribe
CroatiaP20120641► Subscribe
CroatiaP20120613► Subscribe
CroatiaP20110375► Subscribe
CroatiaP20110130► Subscribe
CroatiaP20110147► Subscribe
CroatiaP20090688► Subscribe
Hong Kong1165317► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Chubb
McKesson
Merck
UBS
AstraZeneca
Fuji
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot